Particle therapy is a form of external beam radiotherapy using beams of energetic protons, neutrons, or positive ions for cancer treatment. The most common type of particle therapy as of 2012 is proton therapy. Additionally, electron therapy is generally put into its own category. Because of this, particle therapy is sometimes referred to, more correctly, as hadron therapy.

The global Particle Treatment Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Particle Treatment Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Particle Treatment Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Particle Treatment Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Particle Treatment Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Varian Medical Systems
Ion Beam Applications (IBA)
Mevion Medical Systems
Provision Healthcare
Sumitomo Heavy Industries
Hitachi
Optivus Proton Therapy
Protom International
Advanced Oncotherapy
Danfysik

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Proton Treatment Devices
Heavy Ion Treatment Devices

Segment by Application
Pediatric Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Head and Neck Cancer
Other Cancers